Clinical Trials in Ohio

Showing 13161-13180 of 20,938 trials

Evaluation of Monocyte Volume Distribution Width (MDW) for Early Detection of Sepsis

NCT03145428

The measurement of monocyte volume width distribution (MDW) is intended for use with adult patients presenting to the emergency department (ED), where a CBC with Differential has been ordered, as an aid in the early detection of patients with or developing sepsis. The study will establish the clinical performance of MDW for detection of sepsis in the ED.

SepsisSevere Infection

Beckman Coulter, Inc.3,000 participantsStarted Jun 2017

Hackensack, New Jersey, United States • Columbus, Ohio, United States • Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 281 miles

Diarrhea Predominant Irritable Bowel Syndrome in Females

NCT00461526

Clinical Trial with TRN-002 in Women with Irritable Bowel Syndrome (IBS) The purpose of this study is to investigate the safety and effectiveness of a new investigational drug in women for the treatment of diarrhea-predominant irritable bowel syndrome. The investigational drug is a natural product taken from a plant that grows in South America. The study medication will be administered orally twice a day. Subjects will be not able to remain on certain standard IBS medications (anti-diarrheals) while participating in the study. The total duration of the study is 18 weeks. The study requires five study visits that include physical exams, ECG, blood draws, laboratory studies, and a colon procedure (such as a colonoscopy or flexible sigmoidoscopy if an appropriate procedure has not been performed in the last 5 years.) Participants will be asked to make entries into a touch-tone telephone diary on a daily basis. Participants must meet all of the following criteria: * Females at least 18 years of age * Diagnosis of diarrhea predominant Irritable Bowel Syndrome * Willingness to make daily calls on a touch-tone telephone * Willingness to have an endoscopic and/or radiologic bowel evaluation, if you have not received one in the past 5 years. * Willingness to take an approved method of birth control (if required) Participants CANNOT meet any of the following criteria: * Serious medical or surgical conditions * Colon Cancer, Crohns Disease or Ulcerative Colitis * Pregnant or breast feeding

Irritable Bowel Syndrome

Bausch Health Americas, Inc.240 participantsStarted Oct 2006

Huntsville, Alabama, United States • Chandler, Arizona, United States • Tucson, Arizona, United States +40 more locations

Evaluation of Monocyte Volume Distribution Width (MDW) for Early Detection of Sepsis

Diarrhea Predominant Irritable Bowel Syndrome in Females

Find Trials by Condition in Ohio

Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age

Study to Assess the Safety and Immunogenicity of a Single Dose of GlaxoSmithKline's (GSK) Meningococcal MenACWY-CRM Vaccine (Menveo), Administered to Subjects 15 Through 55 Years of Age, Approximately 4-6 Years After Primary ACWY Vaccination

A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia

New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis

Use of ABI-007 for the Prevention of Vascular Access Graft Failure in Patients Undergoing Hemodialysis

Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections

Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia

Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH)

Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin and Herceptin in Patients With Advanced Breast Cancer

Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer

ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer

Trial of Romidepsin and Bortezomib for Multiple Myeloma

Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer

Study to Assess the Efficacy and Safety of Repeated Administration of BIM 23A760 in Patients With Acromegaly

A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma

LegDeb2 Global Registry for Use of Legflow in Peripheral Arteries